Video Experimental Relacionado
Updated: Sep 9, 2025
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
8.8K
El informe actual sobre el desarrollo de fármacos se centra en "La nueva dimensión" de las características del cáncer
Sisca Ucche1, Yonika Arum Larasati2, Dini Maharani3
1Laboratory of Pharmacology and Toxicology, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281 Yogyakarta, Indonesia.
Gene
|September 3, 2025
Resumen
El descubrimiento de nuevos fármacos contra el cáncer se dirige a características novedosas como la plasticidad celular y la microbiota. Estas pequeñas moléculas tienen como objetivo mejorar las estrategias de tratamiento del cáncer y los resultados de los pacientes.
Área de la Ciencia:
- En el campo de la oncología
- Farmacología
- Biología del cáncer
Sus antecedentes:
- El cáncer sigue siendo un gran desafío para la salud mundial.
- Comprender el desarrollo del cáncer requiere explorar nuevas dimensiones más allá de las características tradicionales.
- La plasticidad fenotípica, la senescencia, la microbiota y la reprogramación epigenética son características emergentes del cáncer.
Objetivo del estudio:
- Revisar los agentes farmacológicos dirigidos a las nuevas características del cáncer.
- Explorar estrategias para desarrollar nuevos tratamientos contra el cáncer.
- Para ayudar a superar los desafíos en la terapia del cáncer.
Principales métodos:
- Revisión de la literatura sobre fármacos anticancerígenos de molécula pequeña.
- Análisis de agentes dirigidos a la plasticidad fenotípica (desdiferenciación, diferenciación bloqueada, transdiferenciación).
- Categoría de los fármacos dirigidos a las células senescentes (agentes senolíticos y senomorfos).
- Examen de los metabolitos microbianos que afectan la eficacia de la quimioterapia.
- Análisis de fármacos dirigidos a la reprogramación epigenética no mutacional (inhibidores de la metilación del ADN, moduladores de la modificación de las histonas, inhibidores de la BET, complejos de remodelación de la cromatina).
Principales resultados:
- Los fármacos de moléculas pequeñas dirigidos a características de nueva dimensión se encuentran en desarrollo preclínico y clínico.
- Los metabolitos microbianos específicos pueden influir en la eficacia quimioterapéutica.
- Los modificadores epigenéticos representan una clase prometedora de agentes contra el cáncer.
Conclusiones:
- Dirigirse a las nuevas características del cáncer ofrece nuevas vías terapéuticas.
- Los agentes farmacológicos que abordan la plasticidad fenotípica, la senescencia, la microbiota y la epigenética son cruciales para las futuras estrategias de tratamiento del cáncer.
- Esta revisión contribuye al desarrollo de enfoques innovadores para mejorar los resultados de los pacientes con cáncer.
Palabras clave:
El cáncerDesarrollo de fármacosLa nueva dimensión características del cáncerLa terapiaMás Videos Relacionados
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.7K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
Videos de Conceptos Relacionados
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
02:18Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509